Open1.285 | Close1.280 |
Vol / Avg.16.157K / 101.729K | Mkt Cap14.973M |
Day Range1.270 - 1.290 | 52 Wk Range1.040 - 2.000 |
Nanoviricides Stock (AMEX: NNVC) stock price, news, charts, stock research, profile.
Open1.285 | Close1.280 |
Vol / Avg.16.157K / 101.729K | Mkt Cap14.973M |
Day Range1.270 - 1.290 | 52 Wk Range1.040 - 2.000 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-01 | EF Hutton | Constantine Davides | Assumes | Buy | Announces | - | 5.25 |
2023-04-18 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 5.25 |
2023-02-28 | EF Hutton | Constantine Davides | Maintains | Buy | Lowers | 8.50 | 5.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NNVC | Nanoviricides | 0.78% | 15M |
GLTO | Galecto | -1.63% | 15.6M |
VIRI | Virios Therapeutics | 0% | 18.1M |
IMPL | Impel Pharmaceuticals | 4.56% | 13.1M |
DOMH | Dominari Holdings | 0% | 12.9M |
You can purchase shares of Nanoviricides (AMEX: NNVC) through any online brokerage.
Other companies in Nanoviricides’s space includes: Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Nanoviricides (AMEX: NNVC) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 5.25 expecting NNVC to rise to within 12 months (a possible 310.19% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Nanoviricides (AMEX: NNVC) is $1.2799 last updated Today at September 23, 2023 at 12:00 AM UTC.
There is no dividend information for Nanoviricides.
Nanoviricides’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Nanoviricides.
Nanoviricides is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Nanoviricides Stock (AMEX: NNVC) stock price, news, charts, stock research, profile.
Open1.285 | Close1.280 |
Vol / Avg.16.157K / 101.729K | Mkt Cap14.973M |
Day Range1.270 - 1.290 | 52 Wk Range1.040 - 2.000 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-01 | EF Hutton | Constantine Davides | Assumes | Buy | Announces | - | 5.25 |
2023-04-18 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 5.25 |
2023-02-28 | EF Hutton | Constantine Davides | Maintains | Buy | Lowers | 8.50 | 5.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NNVC | Nanoviricides | 0.78% | 15M |
GLTO | Galecto | -1.63% | 15.6M |
VIRI | Virios Therapeutics | 0% | 18.1M |
IMPL | Impel Pharmaceuticals | 4.56% | 13.1M |
DOMH | Dominari Holdings | 0% | 12.9M |
You can purchase shares of Nanoviricides (AMEX: NNVC) through any online brokerage.
Other companies in Nanoviricides’s space includes: Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Nanoviricides (AMEX: NNVC) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 5.25 expecting NNVC to rise to within 12 months (a possible 310.19% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Nanoviricides (AMEX: NNVC) is $1.2799 last updated Today at September 23, 2023 at 12:00 AM UTC.
There is no dividend information for Nanoviricides.
Nanoviricides’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Nanoviricides.
Nanoviricides is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Nanoviricides Stock (AMEX: NNVC) stock price, news, charts, stock research, profile.
Open1.285 | Close1.280 |
Vol / Avg.16.157K / 101.729K | Mkt Cap14.973M |
Day Range1.270 - 1.290 | 52 Wk Range1.040 - 2.000 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-01 | EF Hutton | Constantine Davides | Assumes | Buy | Announces | - | 5.25 |
2023-04-18 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 5.25 |
2023-02-28 | EF Hutton | Constantine Davides | Maintains | Buy | Lowers | 8.50 | 5.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NNVC | Nanoviricides | 0.78% | 15M |
GLTO | Galecto | -1.63% | 15.6M |
VIRI | Virios Therapeutics | 0% | 18.1M |
IMPL | Impel Pharmaceuticals | 4.56% | 13.1M |
DOMH | Dominari Holdings | 0% | 12.9M |
You can purchase shares of Nanoviricides (AMEX: NNVC) through any online brokerage.
Other companies in Nanoviricides’s space includes: Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Nanoviricides (AMEX: NNVC) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 5.25 expecting NNVC to rise to within 12 months (a possible 310.19% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Nanoviricides (AMEX: NNVC) is $1.2799 last updated Today at September 23, 2023 at 12:00 AM UTC.
There is no dividend information for Nanoviricides.
Nanoviricides’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Nanoviricides.
Nanoviricides is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Nanoviricides Stock (AMEX: NNVC) stock price, news, charts, stock research, profile.
Open1.285 | Close1.280 |
Vol / Avg.16.157K / 101.729K | Mkt Cap14.973M |
Day Range1.270 - 1.290 | 52 Wk Range1.040 - 2.000 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-01 | EF Hutton | Constantine Davides | Assumes | Buy | Announces | - | 5.25 |
2023-04-18 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 5.25 |
2023-02-28 | EF Hutton | Constantine Davides | Maintains | Buy | Lowers | 8.50 | 5.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NNVC | Nanoviricides | 0.78% | 15M |
GLTO | Galecto | -1.63% | 15.6M |
VIRI | Virios Therapeutics | 0% | 18.1M |
IMPL | Impel Pharmaceuticals | 4.56% | 13.1M |
DOMH | Dominari Holdings | 0% | 12.9M |
You can purchase shares of Nanoviricides (AMEX: NNVC) through any online brokerage.
Other companies in Nanoviricides’s space includes: Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Nanoviricides (AMEX: NNVC) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 5.25 expecting NNVC to rise to within 12 months (a possible 310.19% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Nanoviricides (AMEX: NNVC) is $1.2799 last updated Today at September 23, 2023 at 12:00 AM UTC.
There is no dividend information for Nanoviricides.
Nanoviricides’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Nanoviricides.
Nanoviricides is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Nanoviricides Stock (AMEX: NNVC) stock price, news, charts, stock research, profile.
Open1.285 | Close1.280 |
Vol / Avg.16.157K / 101.729K | Mkt Cap14.973M |
Day Range1.270 - 1.290 | 52 Wk Range1.040 - 2.000 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-01 | EF Hutton | Constantine Davides | Assumes | Buy | Announces | - | 5.25 |
2023-04-18 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 5.25 |
2023-02-28 | EF Hutton | Constantine Davides | Maintains | Buy | Lowers | 8.50 | 5.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NNVC | Nanoviricides | 0.78% | 15M |
GLTO | Galecto | -1.63% | 15.6M |
VIRI | Virios Therapeutics | 0% | 18.1M |
IMPL | Impel Pharmaceuticals | 4.56% | 13.1M |
DOMH | Dominari Holdings | 0% | 12.9M |
You can purchase shares of Nanoviricides (AMEX: NNVC) through any online brokerage.
Other companies in Nanoviricides’s space includes: Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Nanoviricides (AMEX: NNVC) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 5.25 expecting NNVC to rise to within 12 months (a possible 310.19% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Nanoviricides (AMEX: NNVC) is $1.2799 last updated Today at September 23, 2023 at 12:00 AM UTC.
There is no dividend information for Nanoviricides.
Nanoviricides’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Nanoviricides.
Nanoviricides is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Nanoviricides Stock (AMEX: NNVC) stock price, news, charts, stock research, profile.
Open1.285 | Close1.280 |
Vol / Avg.16.157K / 101.729K | Mkt Cap14.973M |
Day Range1.270 - 1.290 | 52 Wk Range1.040 - 2.000 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-01 | EF Hutton | Constantine Davides | Assumes | Buy | Announces | - | 5.25 |
2023-04-18 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 5.25 |
2023-02-28 | EF Hutton | Constantine Davides | Maintains | Buy | Lowers | 8.50 | 5.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NNVC | Nanoviricides | 0.78% | 15M |
GLTO | Galecto | -1.63% | 15.6M |
VIRI | Virios Therapeutics | 0% | 18.1M |
IMPL | Impel Pharmaceuticals | 4.56% | 13.1M |
DOMH | Dominari Holdings | 0% | 12.9M |
You can purchase shares of Nanoviricides (AMEX: NNVC) through any online brokerage.
Other companies in Nanoviricides’s space includes: Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Nanoviricides (AMEX: NNVC) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 5.25 expecting NNVC to rise to within 12 months (a possible 310.19% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Nanoviricides (AMEX: NNVC) is $1.2799 last updated Today at September 23, 2023 at 12:00 AM UTC.
There is no dividend information for Nanoviricides.
Nanoviricides’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Nanoviricides.
Nanoviricides is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Nanoviricides Stock (AMEX: NNVC) stock price, news, charts, stock research, profile.
Open1.285 | Close1.280 |
Vol / Avg.16.157K / 101.729K | Mkt Cap14.973M |
Day Range1.270 - 1.290 | 52 Wk Range1.040 - 2.000 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-01 | EF Hutton | Constantine Davides | Assumes | Buy | Announces | - | 5.25 |
2023-04-18 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 5.25 |
2023-02-28 | EF Hutton | Constantine Davides | Maintains | Buy | Lowers | 8.50 | 5.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NNVC | Nanoviricides | 0.78% | 15M |
GLTO | Galecto | -1.63% | 15.6M |
VIRI | Virios Therapeutics | 0% | 18.1M |
IMPL | Impel Pharmaceuticals | 4.56% | 13.1M |
DOMH | Dominari Holdings | 0% | 12.9M |
You can purchase shares of Nanoviricides (AMEX: NNVC) through any online brokerage.
Other companies in Nanoviricides’s space includes: Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Nanoviricides (AMEX: NNVC) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 5.25 expecting NNVC to rise to within 12 months (a possible 310.19% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Nanoviricides (AMEX: NNVC) is $1.2799 last updated Today at September 23, 2023 at 12:00 AM UTC.
There is no dividend information for Nanoviricides.
Nanoviricides’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Nanoviricides.
Nanoviricides is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Nanoviricides Stock (AMEX: NNVC) stock price, news, charts, stock research, profile.
Open1.285 | Close1.280 |
Vol / Avg.16.157K / 101.729K | Mkt Cap14.973M |
Day Range1.270 - 1.290 | 52 Wk Range1.040 - 2.000 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-01 | EF Hutton | Constantine Davides | Assumes | Buy | Announces | - | 5.25 |
2023-04-18 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 5.25 |
2023-02-28 | EF Hutton | Constantine Davides | Maintains | Buy | Lowers | 8.50 | 5.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NNVC | Nanoviricides | 0.78% | 15M |
GLTO | Galecto | -1.63% | 15.6M |
VIRI | Virios Therapeutics | 0% | 18.1M |
IMPL | Impel Pharmaceuticals | 4.56% | 13.1M |
DOMH | Dominari Holdings | 0% | 12.9M |
You can purchase shares of Nanoviricides (AMEX: NNVC) through any online brokerage.
Other companies in Nanoviricides’s space includes: Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Nanoviricides (AMEX: NNVC) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 5.25 expecting NNVC to rise to within 12 months (a possible 310.19% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Nanoviricides (AMEX: NNVC) is $1.2799 last updated Today at September 23, 2023 at 12:00 AM UTC.
There is no dividend information for Nanoviricides.
Nanoviricides’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Nanoviricides.
Nanoviricides is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Nanoviricides Stock (AMEX: NNVC) stock price, news, charts, stock research, profile.
Open1.285 | Close1.280 |
Vol / Avg.16.157K / 101.729K | Mkt Cap14.973M |
Day Range1.270 - 1.290 | 52 Wk Range1.040 - 2.000 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-01 | EF Hutton | Constantine Davides | Assumes | Buy | Announces | - | 5.25 |
2023-04-18 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 5.25 |
2023-02-28 | EF Hutton | Constantine Davides | Maintains | Buy | Lowers | 8.50 | 5.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NNVC | Nanoviricides | 0.78% | 15M |
GLTO | Galecto | -1.63% | 15.6M |
VIRI | Virios Therapeutics | 0% | 18.1M |
IMPL | Impel Pharmaceuticals | 4.56% | 13.1M |
DOMH | Dominari Holdings | 0% | 12.9M |
You can purchase shares of Nanoviricides (AMEX: NNVC) through any online brokerage.
Other companies in Nanoviricides’s space includes: Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Nanoviricides (AMEX: NNVC) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 5.25 expecting NNVC to rise to within 12 months (a possible 310.19% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Nanoviricides (AMEX: NNVC) is $1.2799 last updated Today at September 23, 2023 at 12:00 AM UTC.
There is no dividend information for Nanoviricides.
Nanoviricides’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Nanoviricides.
Nanoviricides is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.